CHINA PHARMA HOLDINGS, INC. Amortization of Intangible Assets
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Amortization of Intangible Assets of $951.53 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $951.53K, a 504.68% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $825.28K, a 423.28% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $338.58K, a 141.27% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $197.96K, a 88.81% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. amortization of intangible assets for fiscal 2025 was $851.61K, a 90.41% increase from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. amortization of intangible assets for fiscal 2024 was $447.25K, a 99.85% increase from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. amortization of intangible assets for fiscal 2023 was $223.80K, a 512.17% increase from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. amortization of intangible assets for fiscal 2022 was $36.56K, a 4.08% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $951.53K 10-Q · filed 2026-08-14 | $1.78M 10-Q · filed 2026-08-14 | $2.12M derived: sum of 3 quarters · filed 2026-08-14 | $2.31M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $825.28K 10-Q · filed 2026-05-15 | $1.16M derived: sum of 2 quarters · filed 2026-05-15 | $1.36M derived: sum of 3 quarters · filed 2026-05-15 | $1.52M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $338.58K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $536.54K derived: sum of 2 quarters · filed 2026-04-01 | $693.90K derived: sum of 3 quarters · filed 2026-08-14 | $851.61K 10-K · filed 2026-04-01 |
| 2025-09-30 | $197.96K 10-Q · filed 2025-11-12 | $355.32K derived: sum of 2 quarters · filed 2026-08-14 | $513.03K 10-Q · filed 2025-11-12 | $653.36K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $157.36K 10-Q · filed 2026-08-14 | $315.07K 10-Q · filed 2026-08-14 | $455.40K derived: sum of 3 quarters · filed 2026-08-14 | $560.25K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $157.71K 10-Q · filed 2026-05-15 | $298.04K derived: sum of 2 quarters · filed 2026-05-15 | $402.89K derived: sum of 3 quarters · filed 2026-05-15 | $507.81K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $140.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $245.18K derived: sum of 2 quarters · filed 2026-04-01 | $350.10K derived: sum of 3 quarters · filed 2026-04-01 | $447.25K 10-K · filed 2026-04-01 |
| 2024-09-30 | $104.84K 10-Q · filed 2025-11-12 | $209.77K derived: sum of 2 quarters · filed 2025-11-12 | $306.91K 10-Q · filed 2025-11-12 | $369.10K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $104.92K 10-Q · filed 2025-08-14 | $202.07K 10-Q · filed 2025-08-14 | $264.26K derived: sum of 3 quarters · filed 2025-08-14 | $316.77K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $97.08K 10-Q · filed 2025-05-14 | $159.34K derived: sum of 2 quarters · filed 2025-05-14 | $211.85K derived: sum of 3 quarters · filed 2025-05-14 | $267.01K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $62.26K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $114.77K derived: sum of 2 quarters · filed 2025-03-31 | $169.93K derived: sum of 3 quarters · filed 2025-03-31 | $223.80K 10-K · filed 2025-03-31 |
| 2023-09-30 | $52.51K 10-Q · filed 2024-11-13 | $107.67K derived: sum of 2 quarters · filed 2024-11-13 | $161.54K 10-Q · filed 2024-11-13 | $171.48K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $55.16K 10-Q · filed 2024-08-14 | $109.02K 10-Q · filed 2024-08-14 | $118.97K derived: sum of 3 quarters · filed 2024-08-14 | $127.92K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $55.16K 10-Q · filed 2023-05-12 | $63.80K derived: sum of 2 quarters · filed 2024-04-01 | $72.76K derived: sum of 3 quarters · filed 2024-04-01 | $82.44K derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-12-31 | $8.64K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $17.59K derived: sum of 2 quarters · filed 2024-04-01 | $27.27K derived: sum of 3 quarters · filed 2024-04-01 | $36.56K 10-K · filed 2024-04-01 |
| 2022-09-30 | $8.95K 10-Q · filed 2023-11-13 | $18.63K derived: sum of 2 quarters · filed 2023-11-13 | $27.91K 10-Q · filed 2023-11-13 | $37.93K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $9.68K 10-Q · filed 2023-08-14 | $18.96K 10-Q · filed 2023-08-14 | $28.98K derived: sum of 3 quarters · filed 2023-08-14 | $38.48K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $9.68K 10-Q · filed 2023-05-12 | $19.30K derived: sum of 2 quarters · filed 2023-05-12 | $28.80K derived: sum of 3 quarters · filed 2023-05-12 | $38.31K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $9.62K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $19.12K derived: sum of 2 quarters · filed 2023-03-30 | $28.63K derived: sum of 3 quarters · filed 2023-03-30 | $38.11K 10-K · filed 2023-03-30 |
| 2021-09-30 | $9.50K 10-Q · filed 2022-11-14 | $19.02K derived: sum of 2 quarters · filed 2022-11-14 | $28.50K 10-Q · filed 2022-11-14 | $37.77K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $9.52K 10-Q · filed 2022-08-11 | $19.00K 10-Q · filed 2022-08-11 | $28.27K derived: sum of 3 quarters · filed 2022-08-11 | $37.16K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $9.48K 10-Q · filed 2022-05-12 | $18.75K derived: sum of 2 quarters · filed 2022-05-12 | $27.65K derived: sum of 3 quarters · filed 2022-05-12 | $36.32K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $9.27K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $18.17K derived: sum of 2 quarters · filed 2022-03-30 | $26.84K derived: sum of 3 quarters · filed 2022-03-30 | $35.65K 10-K · filed 2022-03-30 |
| 2020-09-30 | $8.89K 10-Q · filed 2021-11-12 | $17.57K derived: sum of 2 quarters · filed 2021-11-12 | $26.38K 10-Q · filed 2021-11-12 | $34.97K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $8.68K 10-Q · filed 2021-08-13 | $17.48K 10-Q · filed 2021-08-13 | $26.08K derived: sum of 3 quarters · filed 2021-08-13 | $34.62K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $8.81K 10-Q · filed 2021-05-14 | $17.40K derived: sum of 2 quarters · filed 2021-05-14 | $25.94K derived: sum of 3 quarters · filed 2021-05-14 | $43.85K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $8.60K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $17.13K derived: sum of 2 quarters · filed 2021-03-26 | $35.04K derived: sum of 3 quarters · filed 2021-03-26 | $57.66K 10-K · filed 2021-03-26 |
| 2019-09-30 | $8.54K 10-Q · filed 2020-11-13 | $26.45K derived: sum of 2 quarters · filed 2020-11-13 | $49.07K 10-Q · filed 2020-11-13 | $70.50K derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $17.91K 10-Q · filed 2020-08-13 | $40.53K 10-Q · filed 2020-08-13 | $61.96K derived: sum of 3 quarters · filed 2020-08-13 | $88.82K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $22.62K 10-Q · filed 2020-05-14 | $44.05K derived: sum of 2 quarters · filed 2020-05-14 | $70.91K derived: sum of 3 quarters · filed 2020-05-14 | $104.34K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $21.43K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $48.29K derived: sum of 2 quarters · filed 2020-03-30 | $81.72K derived: sum of 3 quarters · filed 2020-03-30 | $115.14K 10-K · filed 2020-03-30 |
| 2018-09-30 | $26.86K 10-Q · filed 2019-11-14 | $60.29K derived: sum of 2 quarters · filed 2019-11-14 | $93.72K 10-Q · filed 2019-11-14 | $126.23K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $33.43K 10-Q · filed 2019-08-14 | $66.86K 10-Q · filed 2019-08-14 | $99.37K derived: sum of 3 quarters · filed 2019-08-14 | $139.00K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $33.48K 10-Q · filed 2019-05-14 | $65.94K derived: sum of 2 quarters · filed 2019-05-14 | $105.57K derived: sum of 3 quarters · filed 2019-05-14 | $148.09K derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $32.46K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $72.09K derived: sum of 2 quarters · filed 2019-03-28 | $114.61K derived: sum of 3 quarters · filed 2019-03-28 | $165.39K 10-K · filed 2019-03-28 |
| 2017-09-30 | $39.63K 10-Q · filed 2018-11-14 | $82.16K derived: sum of 2 quarters · filed 2018-11-14 | $132.94K 10-Q · filed 2018-11-14 | $196.24K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $42.53K 10-Q · filed 2018-08-14 | $93.31K 10-Q · filed 2018-08-14 | $156.61K derived: sum of 3 quarters · filed 2018-08-14 | $222.25K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $50.78K 10-Q · filed 2018-05-14 | $114.08K derived: sum of 2 quarters · filed 2018-05-14 | $179.72K derived: sum of 3 quarters · filed 2018-05-14 | $246.75K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $63.30K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $128.94K derived: sum of 2 quarters · filed 2018-04-02 | $195.97K derived: sum of 3 quarters · filed 2018-04-02 | $262.91K 10-K · filed 2018-04-02 |
| 2016-09-30 | $65.64K 10-Q · filed 2017-11-14 | $132.67K derived: sum of 2 quarters · filed 2017-11-14 | $199.61K 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $67.03K 10-Q · filed 2017-08-14 | $133.97K 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |